Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control

Cell Cycle

Volumn 11, Issue 6, 2012, Pages 1167-1173

  Golding, Sarah E ^a   Rosenberg, Elizabeth ^a   Adams, Bret R ^a   Wignarajah, Shayalini ^a   Beckta, Jason M ^a,b   O'Connor, Mark J ^c   Valerie, Kristoffer ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

AKT; DNA repair; KU 60019; Temozolomide

Indexed keywords

ATM PROTEIN; HISTONE H2AX; KU 60019; PROTEIN KINASE B; PROTEIN P53; PROTEIN SERINE THREONINE KINASE INHIBITOR; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL KILLING; CONTROLLED STUDY; DNA DAMAGE; EMBRYONIC STEM CELL; ENZYME INHIBITION; GLIOBLASTOMA; GLIOMA CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PROTEIN PHOSPHORYLATION; RADIOSENSITIZATION; SENSITIZATION; TUMOR CELL LINE; TUMOR GROWTH;

EID: 84858722796     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.6.19576     Document Type: Article

References (27)

1. Stupp R, Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007; 25:4127-36; PMID:17827463; http://dx.doi. org/10.1200/JCO.2007.11.8554.
2. Niyazi M, Siefert A, Schwarz SB, Ganswindt U, Kreth FW, Tonn JC, et al. Therapeutic options for recurrent malignant glioma. Radiother Oncol 2011; 98:1-14; PMID:21159396; http://dx.doi.org/10.1016/j.radonc.2010.11.006.
3. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359:492-507; PMID:18669428; http:// dx.doi.org/10.1056/NEJMra0708126.
4. Taphoorn MJ, Sizoo EM, Bottomley A. Review on quality of life issues in patients with primary brain tumors. Oncologist 2010; 15:618-26; PMID:20507891; http://dx.doi.org/10.1634/theoncologist.2009-0291.
5. Squatrito M, Holland EC. DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance. Cancer Res 2011; 71:5945-9; PMID:21917735; http://dx.doi.org/10.1158/0008-5472.CAN-11-1245.
6. Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9:759-69; PMID:18813293; http:// dx.doi.org/10.1038/nrm2514.
7. Golding SE, Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, et al. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther 2009; 8:2894-902; PMID:19808981; http://dx.doi.org/10.1158/1535-7163.MCT-09-0519.
8. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 2004; 64:9152-9; PMID:15604286; http://dx.doi.org/10.1158/0008-5472.CAN-04-2727.
9. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998; 280:1089-91; PMID:9582124; http://dx.doi.org/10.1126/ science.280.5366.1089.
10. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13:152-7; PMID:9925639; http://dx.doi.org/10.1101/gad.13.2.152.
11. Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Löbrich M, Jeggo PA. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 2004; 64:2390-6; PMID:15059890; http://dx.doi.org/10. 1158/0008-5472.CAN-03-3207.
12. Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, et al. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem 2007; 282:36177-89; PMID:17942393; http:// dx.doi.org/10.1074/jbc.M706912200.
13. Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys 2009; 75:1511-9; PMID:19931733; http://dx.doi.org/10. 1016/j.ijrobp.2009.07.1703.
14. Adams BR, Golding SE, Rao RR, Valerie K. Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS One 2010; 5:10001; PMID:20368801; http://dx.doi.org/10.1371/ journal.pone.0010001.
15. White JS, Choi S, Bakkenist CJ. Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange. Sci Signal 2010; 3:44; PMID:20516478; http://dx.doi.org/10.1126/scisignal.2000758.
16. Rainey MD, Charlton ME, Stanton RV, Kastan MB. Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation. Cancer Res 2008; 68:7466-74; PMID:18794134; http://dx.doi.org/10.1158/0008-5472. CAN-08-0763.
17. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology and paths to treatment. Genes Dev 2007; 21:2683-710; PMID:17974913; http:// dx.doi.org/10.1101/gad.1596707.
18. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Molecularly targeted therapy for malignant glioma. Cancer 2007; 110:13- 24; PMID:17520692; http://dx.doi.org/10.1002/cncr.22741.
19. Weber GL, Parat MO, Binder ZA, Gallia GL, Riggins GJ. Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration and invasion in glioblastoma multiforme cells. Oncotarget 2011; 2:833-49; PMID:22064833.
20. Hawkins AJ, Golding SE, Khalil A, Valerie K. DNA double-strand break-induced pro-survival signaling. Radiother Oncol 2011; 101:13-7; PMID:21726915; http://dx.doi.org/10.1016/j.radonc.2011.05.074.
21. Choi S, Gamper AM, White JS, Bakkenist CJ. Inhibition of ATM kinase activity does not phenocopy ATM protein disruption: implications for the clinical utility of ATM kinase inhibitors. Cell Cycle 2010; 9:4052-7; PMID:20953138; http://dx.doi.org/10.4161/cc.9.20.13471.
22. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61:2744-50; PMID:11289157.
23. Gosink EC, Chong MJ, McKinnon PJ. Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity. Cancer Res 1999; 59:5294-8; PMID:10537312.
24. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-60; PMID:17051156; http:// dx.doi.org/10.1038/ nature05236.
25. Khalil A, Morgan RN, Adams BR, Golding SE, Dever SM, Rosenberg E, et al. ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks. Cell Cycle 2011; 10:481-91; PMID:21263216; http:// dx.doi.org/10.4161/cc.10.3. 14713.
26. Golding SE, Valerie K. MRE11 and ATM AKTivate pro-survival signaling. Cell Cycle 2011; 10:3227-36; PMID:21946569; http://dx.doi.org/10.4161/cc.10.19. 17048.
27. Fraser M, Harding SM, Zhao H, Coackley C, Durocher D, Bristow RG. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks. Cell Cycle 2011; 10:2218-32; PMID:21623170; http://dx.doi.org/10.4161/cc.10.13. 16305.